Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He is currently finishing up a Master’s degree in communications at Georgetown University.

Latest Posts

USA Today: Vaccine opt-outs put public health at risk

Vaccine-Opt-Outs

In an editorial yesterday, USA Today’s editors called attention to a growing public health problem: the resurgence of vaccine preventable illnesses as a result of parents choosing to forgo vaccinating their children. The paper notes recent outbreaks of measles in small clusters, including Orange County, California, which saw 22 cases reported this month, and Brooklyn, New York. In all of 2013, there were 189 cases reported nationwide. Already this year, we’ve seen 115 cases, in Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Calls for Adequate Funding of Vaccine and Biodefense Programs

flu-syringe

It’s budget time here in Washington, with appropriators in the House and Senate working overtime to craft a budget that can pass both chambers and keep our government funded for another year – not always the easiest of tasks. Here at BIO, we’ve been just as busy working to ensure that the FY 2015 budget contains adequate funding for a host of programs that encourage medical innovation, robust public health and emergency preparedness programs, and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

FDA: Vaccines a Critical Tool in Protecting and Promoting Public Health

FDA115x76

Yesterday, Dr. Karen Midthun of the FDA wrote about the important role of vaccines in promoting public health: Vaccines are a critical tool in protecting and promoting the public health in the U.S. and around the world. The risks from childhood diseases like measles, mumps and polio have been greatly reduced, or in the case of polio, eliminated in the U.S. Vaccines are one of the great public health success stories of the 20th century. Dr. Midlun Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Economist – Biotechnology: Fever Rising

The-Economist-115x76

After speaking with several attendees and speakers at last week’s BIO CEO & Investor Conference, the Economist featured an article this week about the strong performance of biotech equities recently: AS INVESTORS and executives crammed into a New York ballroom for a conference held this week by the Biotechnology Industry Organisation, the mood was jittery. The previous week eight biotech firms had launched initial public offerings in America, together raising more than $500m. In a discussion Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , ,

Business Roundtable: The Reimbursement Landscape under ACA

Capture

As the Affordable Care Act is implemented, reimbursement for life-saving and life-enhancing drugs is one of the most pressing issues facing healthcare stakeholders and decision makers, including patients, payers, providers, and innovative drug developers. BIO hosted a business roundtable discussion on this timely topic yesterday at our 16th Annual BIO CEO & Investor Conference. Moderated by Real Endpoint’s Roger Longman, panelists represented a variety of perspectives: Peter Bach, MD, MAPP, Attending Physician, Memorial Sloan-Kettering Cancer Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,